Embla Medical

What Embla Medical does

Embla Medical hf., headquartered in Reykjavik, Iceland and listed on Nasdaq Copenhagen (ticker: EMBLA), is a global provider of prosthetics, orthotics, bracing and supports, and patient care services for people with limb loss, limb difference, and mobility challenges. The company operates a multi-brand architecture comprising Össur (prosthetics and bracing), Fior & Gentz (neuro orthotics), College Park (lower-limb prosthetics), ForMotion (the global network of patient care clinics), and the more recently acquired Naked Prosthetics (finger and partial-hand prostheses) and Streifeneder ortho.production (orthopedic mobility solutions, 51% majority). Embla's technology portfolio spans microprocessor-controlled knees (POWER KNEE, marketed as the world's first actively powered bionic knee), myoelectric upper-limb devices (i-Limb), carbon-fiber sports blades (Cheetah), silicone interface systems (Iceross, the 1986 first global patent that became standard of care), and intelligent prosthetic feet (Proprio Foot, Pro-Flex, Balance, Odyssey iQ). With over 2,100 registered patents and R&D investment of approximately 5% of annual revenue, the company is the most patent-dense Icelandic life-sciences business, with specialized R&D hubs in Reykjavik, Livingston (Scotland, upper limb), and Olympia, Washington (finger prosthetics).

Embla's business model blends hardware sales (Prosthetics & Neuro Orthotics contributed 51% of 2025 sales at USD 474M; Bracing & Supports contributed 16% at USD 149M) with professional patient-care services through its ForMotion clinic network (33% of 2025 sales at USD 306M). The company sells primarily through direct field sales to O&P clinics, hospitals, and prosthetic providers across ~40 countries, complemented by branded athlete sponsorships (Team Össur) and clinical-channel marketing. 2025 net sales of USD 929M (the highest in the company's history) generated 20% EBITDA margins, USD 84M net profit (up 21%), and USD 100M of free cash flow, with regional split of EMEA 49%, Americas 43%, and APAC 8%. The customer base is structurally long-tail (individual amputees and mobility-impaired patients served through fragmented clinical channels), and pricing is reimbursement-driven. Strategic priorities visible in 2024-2026 include the Streifeneder majority acquisition, a three-year USD 11M partnership with the Government of Iceland to serve Ukrainian amputees via a new Kyiv clinic, leadership refresh (new COO and EVP R&D), and ongoing product launches in the core prosthetics segment.

Name

Embla Medical

Legal name

Embla Medical hf.

Website

https://emblamedical.com

Company type

Public

Founded year

1971

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Embla Medical is a global provider of prosthetics, orthotics, bracing, and patient care services for amputees and people with mobility challenges, operating through the Össur, Fior & Gentz, College Park, and ForMotion brands across approximately 40 countries with USD 929M in 2025 revenue.

Ownership category

akta.pro rank

Product category

Orthotic and Prosthetic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems) (HLAHAEAH)

akta.pro secondary industries

Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets) (HLAHAMAD), Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses) (HLAHAEAI), Sports & Active Rehabilitation Devices (Adaptive Sports Mobility, Performance Prosthetics) (HLAHAMAJ), Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN)

Keywords

• Prosthetic devices
• Orthotic solutions
• Mobility care services
• Microprocessor prosthetics
• Orthopedic bracing supports

Headquarters

HQ city

Reykjavík

HQ country

Iceland

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Prosthetics & Neuro Orthotics Products: Design, manufacture and sale of prosthetic devices including microprocessor knees, feet, sports blades, and upper limb prosthetics, as well as neuro orthotic solutions. Contributed 51% of 2025 sales (USD 474 million).
2. Bracing & Supports: Bracing and support solutions for mobility assistance. Contributed 16% of 2025 sales (USD 149 million).
3. Patient Care Services: Patient care services through global network of ForMotion O&P clinics providing prosthetic fitting, rehabilitation and ongoing patient care. Contributed 33% of 2025 sales (USD 306 million).
4. Strategic Acquisitions: Growth through acquisitions including Streifeneder ortho.production (51% majority stake) and Naked Prosthetics, expanding product portfolio and market reach.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels7 records

Core offering

Embla Medical designs, manufactures, and sells prosthetic limbs, neuro orthotic devices, and bracing & supports products through brands including Össur, Fior & Gentz, College Park, and Naked Prosthetics. The company also operates a global network of ForMotion Orthotic & Prosthetic patient care clinics providing prosthetic fitting, rehabilitation, and ongoing patient care services.

Product overview

Embla Medical is a leading global provider of innovative mobility solutions offering a comprehensive portfolio across prosthetics, neuro orthotics, bracing & supports, and patient care. The company operates under a platform-plus-brands architecture, unified under the Embla Medical parent company. Key brands include Össur (prosthetics and bracing solutions), Fior & Gentz (neuro orthotics), College Park (lower limb prosthetics), and ForMotion (global patient care clinic network). The company also acquired Naked Prosthetics to expand upper limb offerings. Products span from microprocessor-controlled knees (POWER KNEE™) and running blades (Cheetah®) to myoelectric hands (i-Limb®), prosthetic feet (Pro-Flex, Balance™), and neuro orthotic devices, supported by a global network of patient care clinics.

Differentiator

Problem solved

Functional benefit

Brands

• Össur: Leading global provider of prosthetics and bracing & supports solutions. Core brand for lower limb prosthetics including Cheetah sports blades, POWER KNEE, and i-Limb upper limb prostheses.
• Fior & Gentz
• College Park
• ForMotion
• Naked Prosthetics

Products and services

• Össur Prosthetics and Bracing
• POWER KNEE
• i-Limb
• Cheetah Sports Blades
• Fior & Gentz Neuro Orthotics
• College Park Lower Limb Prosthetics
• Naked Prosthetics Finger Prostheses
• Odyssey iQ Foot
• ForMotion Patient Care Services
• Bracing & Supports
• Pro-Flex Prosthetic Feet
• Balance Foot Prostheses
• Proprio Foot
• Rheo Knee XC

Quantifiable outcome

• 22 medals won by para athletes using Össur technology at Paris 2024 Paralympics
• +3 more outcomes

Named customers9 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eleven partnerships are on record, tiered minor and core.

• Nordic CompassminorStrategic or Co-development Partner · 12 May 2026Industry-led alliance to strengthen Nordic and European competitiveness, resilience and industrial innovation. Founding partner alongside companies including Novo Nordisk, EQT Group, Nokia, and others. First initiatives to be presented at Nordic Compass Summit in November 2026.
• Government of IcelandcoreStrategic or Co-development Partner · 6 November 2025Three-year partnership valued at USD 11 million to provide prosthetic care for up to 1,000 Ukrainian amputees through new Kyiv clinic. Co-financed by Government of Iceland and Embla Medical, with Future for Ukraine serving as implementing partner. Addresses unprecedented need with 50,000+ amputations since 2022 Russian invasion.
• Future for Ukraine (FFU)coreImplementation/ SI/ Consulting Partner · 6 November 2025Charity organization serving as implementing partner for Ukraine prosthetic care initiative. Coordinating clinic operations and patient matching for up to 1,000 Ukrainian amputees.
• Streifeneder ortho.production GmbHcoreStrategic or Co-development Partner · 1 September 2025Majority share investment (51%) completed in September 2025 after regulatory approval. Positions Embla Medical as full-range provider and strengthens presence in key markets and less developed healthcare markets. Deal involved issuing new shares raising approximately EUR 12.5 million.
• NissanminorStrategic or Co-development Partner · 14 October 2024Partnership with Nissan for Richard Whitehead Foundation and Nissan Possibilities Project since 2021. Technical collaboration modified Nissan ARIYA for Richard Whitehead's prosthetic needs, enabling record-breaking Chicago Marathon performance.
• Protez Hub FoundationcoreImplementation/ SI/ Consulting Partner · 16 October 2023Ukrainian nonprofit organization spearheading educational efforts and championing sustainable development of limb prosthetics industry. Partnered for multi-disciplinary training of 19 Ukrainian medical professionals at Össur facility in Köln.
• ProsthetiKacoreImplementation/ SI/ Consulting Partner · 16 October 2023Nonprofit organization coordinating prosthetic assistance for Ukrainian amputees. Partnership to ensure ongoing rehabilitation and sustainable clinical care through local Ukrainian prosthetists.
• OttobockminorStrategic or Co-development Partner · 10 May 2022Co-founded Össur and Ottobock Research Trust Fund at University of Iceland with USD 150,000-500,000 funding per project for research on man-machine interfaces for prosthetic benefit.
• Alfred Mann FoundationminorStrategic or Co-development Partner · 4 November 2019Agreement to extend exploration of mind-controlled prosthetics technology for advanced neural control of prosthetic limbs.
• NikeminorStrategic or Co-development Partner · 11 April 2019Nike Sole partnership on Össur Cheetah sports blade, combining Nike footwear technology with Össur prosthetic expertise for athletes.
• Danish National Olympic Committee & Sports ConfederationminorGTM or Marketing Partner · 11 April 2019Partnership for para-athletic sponsorship and Olympic movement support in Denmark.

Scale indicators17 records

Recent moves8 records

Expansion highlights6 records

Market position

Strengths1 record

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/embla-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries6 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Embla Medical